Nuvectis Pharma Inc (NVCT)

SG&A Expense Growth

35.96%

Fiscal year · Period ending:

NVCT logo

NVCT SG&A Expense Growth

Latest reported35.96%
NVCT FY SG&A Growth (YoY) (0.00% → 35.96%)
High-resolution chart · PNG

NVCT sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuvectis Pharma Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
35.9648%
-7.8223%
25.1373%
79.367%
33,390%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.